<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="eds6" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">eds6</book-part-id>
      <title-group>
        <title>Ehlers-Danlos Syndrome, Kyphoscoliotic Form</title>
        <alt-title alt-title-type="alt-title">Synonyms: EDS, Kyphoscoliotic Form; EDS Type VI; EDS VI; Ehlers-Danlos Syndrome Type VI; Lysyl-Hydroxylase Deficiency</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Yeowell</surname>
            <given-names>Heather N</given-names>
          </name>
          <xref ref-type="aff" rid="eds6.AFF1"/>
          <degrees>PhD</degrees>
          <email>Heather.yeowell@duke.edu</email>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Steinmann</surname>
            <given-names>Beat</given-names>
          </name>
          <xref ref-type="aff" rid="eds6.AFF2"/>
          <degrees>MD</degrees>
          <email>Beat.Steinmann@kispi.uzh.ch</email>
        </contrib>
      </contrib-group>
      <aff id="eds6.AFF1">Department of Dermatology<break/>Duke University Medical Center<break/>Durham, North Carolina</aff>
      <aff id="eds6.AFF2">Division of Metabolism, Connective Tissue Unit<break/>University Children's Hospital <break/>Zurich, Switzerland</aff>
      <pub-history>
        <date iso-8601-date="2000-02-02" date-type="created">
          <day>02</day>
          <month>02</month>
          <year>2000</year>
        </date>
        <date iso-8601-date="2013-01-24" date-type="updated">
          <day>24</day>
          <month>01</month>
          <year>2013</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="eds3" document-type="chapter">Ehlers-Danlos Syndrome, Hypermobility Type</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="emanuel" document-type="chapter">Emanuel Syndrome</related-object>
      <abstract id="eds6.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Ehlers-Danlos syndrome (EDS), kyphoscoliotic form (previously known as EDS VI) is a generalized connective tissue disorder characterized by friable, hyperextensible skin, thin scars, and easy bruising; generalized joint laxity; severe muscular hypotonia at birth; progressive scoliosis, present at birth or within the first year of life; and scleral fragility with increased risk of rupture of the globe. Intelligence is normal; life span may be normal, but affected individuals are at risk for rupture of medium-sized arteries and respiratory compromise if kyphoscoliosis is severe. </p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>EDS, kyphoscoliotic form is caused by deficient activity of the enzyme procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 (PLOD1, or lysyl hydroxylase 1). The diagnosis of EDS, kyphoscoliotic form relies on the demonstration of a markedly increased ratio of deoxypyridinoline to pyridinoline crosslinks in urine measured by high-performance liquid chromatography (HPLC) (a highly sensitive, specific, and inexpensive test) and/or assay of lysyl hydroxylase enzyme activity in skin fibroblasts. <italic toggle="yes">PLOD1</italic> is the only gene in which mutations are known to cause EDS, kyphoscoliotic form. </p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Management of kyphoscoliosis by an orthopedic surgeon, including surgery as needed; physical therapy to strengthen large muscle groups; bracing to support unstable joints; protective pads and helmets during active sports; control of blood pressure to reduce the risk for arterial rupture; treatment with beta blockers as needed to prevent aortic dilation. </p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Standard American Heart Association guidelines for antimicrobial prophylaxis for mitral valve prolapse. </p>
          <p><italic toggle="yes">Surveillance:</italic> Routine ophthalmologic examination; routine examination for inguinal hernia; regular follow-up by an orthopedic surgeon; echocardiogram at five-year intervals even if the initial echocardiogram is normal. </p>
          <p><italic toggle="yes">Agents/circumstances to avoid</italic>: Sports that impact the joints, such as gymnastics or long-distance running.</p>
          <p><italic toggle="yes">Pregnancy management</italic>: Affected pregnant women may be at increased risk for spontaneous abortions, premature rupture of membranes, and rupture of arteries.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>EDS, kyphoscoliotic form is inherited in an autosomal recessive manner. At conception, each sib of a proband with EDS, kyphoscoliotic form has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Prenatal testing for pregnancies at increased risk is possible once the disease-causing mutations have been identified in the family.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="eds6.Diagnosis">
        <title>Diagnosis</title>
        <sec id="eds6.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The major and minor clinical features of Ehlers-Danlos syndrome (EDS), kyphoscoliotic form have been outlined by <xref ref-type="bibr" rid="eds6.REF.beighton.1998.31">Beighton et al [1998]</xref>. </p>
          <p><bold>Major clinical features</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>Friable, hyperextensible skin, thin scars, easy bruising </p>
            </list-item>
            <list-item>
              <p>Generalized joint laxity </p>
            </list-item>
            <list-item>
              <p>Severe muscle hypotonia at birth </p>
            </list-item>
            <list-item>
              <p>Progressive scoliosis, present at birth or within the first year of life </p>
            </list-item>
            <list-item>
              <p>Scleral fragility and rupture of the globe </p>
            </list-item>
          </list>
          <p><bold>Minor clinical features</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>Widened, atrophic scars </p>
            </list-item>
            <list-item>
              <p>Marfanoid habitus </p>
            </list-item>
            <list-item>
              <p>Rupture of medium-sized arteries </p>
            </list-item>
            <list-item>
              <p>Mild to moderate delay of attainment of gross motor milestones </p>
            </list-item>
          </list>
          <p>The presence of three major clinical features is highly suggestive of EDS, kyphoscoliotic form. </p>
        </sec>
        <sec id="eds6.Testing">
          <title>Testing</title>
          <p>
            <bold>Affected individuals</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Biochemical testing.</bold> Deficiency of the enzyme procollagen-lysine, 2-oxoglutarate 5 dioxygenase-1 (PLOD1) results in a deficiency in hydroxylysine-based pyridinoline cross-links in collagens. Detection of an increased ratio of deoxypyridinoline (Dpyr) to pyridinoline (Pyr) cross-links in urine quantitated by high-performance liquid chromatography (HPLC) is a highly sensitive and specific test for EDS, kyphoscoliotic form. The normal ratio of Dpyr:Pyr cross-links is approximately 0.2, whereas in EDS, kyphoscoliotic form, the ratio is approximately 6.0 [<xref ref-type="bibr" rid="eds6.REF.steinmann.1995.1505">Steinmann et al 1995</xref>, <xref ref-type="bibr" rid="eds6.REF.alhussain.2004.28">Al-Hussain et al 2004</xref>]. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) can be used to detect faster migration of underhydroxylated collagen chains and their derivatives.</p>
            </list-item>
            <list-item>
              <p><bold>Enzyme assay.</bold> Activity of the enzyme PLOD1 can be measured in cultured fibroblasts. In individuals with EDS, kyphoscoliotic form, enzyme activity is below 25% of normal [<xref ref-type="bibr" rid="eds6.REF.yeowell.2000.212">Yeowell &#x00026; Walker 2000</xref>]. </p>
            </list-item>
          </list>
          <p><bold>Carriers.</bold> Carriers cannot be detected by biochemical testing or by enzyme assay. </p>
          <sec id="eds6.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Gene.</bold>
<italic toggle="yes">PLOD1</italic> is the only gene in which mutations are known to cause EDS, kyphoscoliotic form. </p>
            <p><bold>Clinical testing</bold>
</p>
            <table-wrap id="eds6.T.summary_of_molecular_genetic_test" position="anchor" orientation="portrait">
              <label>Table 1.</label>
              <caption>
                <p>Summary of Molecular Genetic Testing used in EDS, Kyphoscoliotic Form</p>
              </caption>
              <table>
                <tbody>
                  <tr>
                    <th id="hd_b_eds6.T.summary_of_molecular_genetic_test_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_b_eds6.T.summary_of_molecular_genetic_test_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_b_eds6.T.summary_of_molecular_genetic_test_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Mutations Detected&#x000a0;<sup>2</sup></th>
                    <th id="hd_b_eds6.T.summary_of_molecular_genetic_test_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Mutation Detection Frequency by Test Method&#x000a0;<sup>3</sup></th>
                  </tr>
                  <tr>
                    <td headers="hd_b_eds6.T.summary_of_molecular_genetic_test_1_1_1_1" align="left" valign="middle" rowspan="2" colspan="1">
                      <italic toggle="yes">PLOD1</italic>
                    </td>
                    <td headers="hd_b_eds6.T.summary_of_molecular_genetic_test_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                    <td headers="hd_b_eds6.T.summary_of_molecular_genetic_test_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_b_eds6.T.summary_of_molecular_genetic_test_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Unknown</td>
                  </tr>
                  <tr>
                    <td headers="hd_b_eds6.T.summary_of_molecular_genetic_test_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                    <td headers="hd_b_eds6.T.summary_of_molecular_genetic_test_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Intragenic deletions/duplications</td>
                    <td headers="hd_b_eds6.T.summary_of_molecular_genetic_test_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">~18%&#x000a0;<sup>6</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="eds6.TF.1">
                  <label>1.</label>
                  <p>See <related-object source-id="gene" document-id="eds6" object-id="eds6.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. </p>
                </fn>
                <fn id="eds6.TF.1.1">
                  <label>2.</label>
                  <p>See <xref ref-type="sec" rid="eds6.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
                </fn>
                <fn id="eds6.TF.1.2">
                  <label>3.</label>
                  <p>The ability of the test method used to detect a mutation that is present in the indicated gene</p>
                </fn>
                <fn id="eds6.TF.1.3">
                  <label>4.</label>
                  <p>Examples of mutations detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site mutations; typically, exonic or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="eds6.TF.1.4">
                  <label>5.</label>
                  <p>Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
                </fn>
                <fn id="eds6.TF.1.5">
                  <label>6.</label>
                  <p>An intragenic duplication caused by an Alu-Alu recombination in introns 9 and 16 is the most common mutant allele, with a frequency of 18.3% in 53 families with EDS, kyphoscoliotic form [<xref ref-type="bibr" rid="eds6.REF.yeowell.2005.353">Yeowell et al 2005</xref>]. The duplication can be confirmed in genomic DNA by PCR using duplication-specific primers [<xref ref-type="bibr" rid="eds6.REF.pousi.1994.899">Pousi et al 1994</xref>, <xref ref-type="bibr" rid="eds6.REF.giunta.2005b.269">Giunta et al 2005b</xref>]. Deletions of 3 and 5.5 kb have also been reported [<xref ref-type="bibr" rid="eds6.REF.pousi.1998.55">Pousi et al 1998</xref>, <xref ref-type="bibr" rid="eds6.REF.giunta.2009.346">Giunta et al 2009</xref>].</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Test characteristics.</bold> Information on test sensitivity, specificity, and other test characteristics can be found at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.eurogentest.org/web/info/public/unit3/geneCards.xhtml">www.eurogentest.org</ext-link> [<xref ref-type="bibr" rid="eds6.REF.mayer.2013.1">Mayer et al 2013</xref> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nature.com/ejhg/journal/v21/n1/pdf/ejhg2012162a.pdf">full text</ext-link>)].</p>
          </sec>
        </sec>
        <sec id="eds6.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To confirm/establish the diagnosis in a proband,</bold> the following testing can be pursued:</p>
          <list list-type="bullet">
            <list-item>
              <p>Urinary cross-link analysis to determine the ratio of deoxypyridinoline (Dpyr) to pyridinoline (Pyr) cross-links [<xref ref-type="bibr" rid="eds6.REF.kraenzlin.2008.1546">Kraenzlin et al 2008</xref>]</p>
            </list-item>
            <list-item>
              <p>Confirmatory molecular genetic testing of <italic toggle="yes">PLOD1</italic> through sequence analysis [<xref ref-type="bibr" rid="eds6.REF.giunta.2005b.269">Giunta et al 2005b</xref>]. If no mutation is identified, deletion/duplication analysis can be pursued.</p>
            </list-item>
            <list-item>
              <p>Lysyl hydroxylase activity assay in cultured fibroblasts</p>
            </list-item>
          </list>
          <p><bold>Carrier testing for at-risk relatives</bold> requires prior identification of the disease-causing mutations in the family.</p>
          <p>Note: Carriers are heterozygotes for this autosomal recessive disorder and are not at risk of developing the disorder.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the disease-causing mutations in the family.</p>
        </sec>
      </sec>
      <sec id="eds6.Clinical_Description">
        <title>Clinical Characteristics</title>
        <sec id="eds6.Natural_History">
          <title>Clinical Description</title>
          <p>A range of clinical severity is observed in individuals with EDS, kyphoscoliotic form for each of the systems discussed in this section [<xref ref-type="bibr" rid="eds6.REF.steinmann.2002.1">Steinmann et al 2002</xref>, <xref ref-type="bibr" rid="eds6.REF.rohrbach.2011.46">Rohrbach et al 2011</xref>].</p>
          <p><bold>Prenatal.</bold> Pregnancy involving an affected fetus may be complicated by premature rupture of membranes. </p>
          <p>
            <bold>Musculoskeletal</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Muscular hypotonia with joint laxity is present in neonates. Muscular weakness is common, may be severe with wrist drop, and may lead to upper brachial plexus palsy. Attainment of gross motor milestones may be mildly to moderately delayed, but walking nearly always occurs before age two years; loss of motor milestones does not occur. Intellect is unaffected. </p>
            </list-item>
            <list-item>
              <p>A marfanoid habitus is often striking.</p>
            </list-item>
            <list-item>
              <p>Thoracic scoliosis is common in the neonate. The kyphoscoliosis appears during infancy and becomes moderate to severe in childhood. Adults with severe kyphoscoliosis are at risk for complications from restrictive lung disease, recurrent pneumonia, and cardiac failure. </p>
            </list-item>
            <list-item>
              <p>Clubfoot (equinovarus) deformities are present at birth in approximately 30% of affected individuals. </p>
            </list-item>
            <list-item>
              <p>Recurrent joint dislocations are a common serious problem.</p>
            </list-item>
            <list-item>
              <p>Osteopenia/osteoporosis occurs in all individuals.</p>
            </list-item>
          </list>
          <p>
            <bold>Eyes</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Ocular fragility, which was observed in the original reports of individuals with procollagen lysyl hydroxylase deficiency [<xref ref-type="bibr" rid="eds6.REF.pinnell.1972.1013">Pinnell et al 1972</xref>], is found in a minority of individuals. </p>
            </list-item>
            <list-item>
              <p>High myopia is common.</p>
            </list-item>
            <list-item>
              <p>Many individuals have microcornea, although its clinical significance is unclear.</p>
            </list-item>
            <list-item>
              <p>Glaucoma and retinal detachment also occur.</p>
            </list-item>
          </list>
          <p>
            <bold>Cardiovascular</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Vascular rupture is the major life-threatening complication in this disorder. In one series, three of ten individuals had vascular rupture. Both aortic dilation/dissection and rupture of medium-sized arteries may occur. The rate of progression of aortic root dilation in EDS, kyphoscoliotic form is not known. </p>
            </list-item>
            <list-item>
              <p>Mitral valve prolapse is common.</p>
            </list-item>
            <list-item>
              <p>Venous ectasis following use of intravenous catheters has been reported [<xref ref-type="bibr" rid="eds6.REF.heim.1998.708">Heim et al 1998</xref>]. </p>
            </list-item>
          </list>
          <p>
            <bold>Skin</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>All individuals with EDS, kyphoscoliotic form have hyperelastic and easily stretched skin. </p>
            </list-item>
            <list-item>
              <p>An estimated 60% of individuals have abnormal scarring, characterized by thinness and widening.</p>
            </list-item>
            <list-item>
              <p>Bruising occurs easily in all individuals and severe bruising occurs in approximately 50%.</p>
            </list-item>
          </list>
        </sec>
        <sec id="eds6.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Genotype-phenotype correlations that predict risk for specific complications or clinical severity do not exist. </p>
        </sec>
        <sec id="eds6.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance for EDS, kyphoscoliotic form is 100%.</p>
        </sec>
        <sec id="eds6.Nomenclature">
          <title>Nomenclature</title>
          <p>EDS, kyphoscoliotic form was initially referred to as EDS, oculoscoliotic form after its first description by <xref ref-type="bibr" rid="eds6.REF.pinnell.1972.1013">Pinnell et al [1972]</xref>.</p>
          <p>Prior to the development of the 1998 Villefranche classification, EDS, kyphoscoliotic form was known as EDS VI (or EDS VIA).</p>
          <p><xref ref-type="bibr" rid="eds6.REF.giunta.2005a.158">Giunta et al [2005a]</xref> convincingly demonstrated that Nevo syndrome is part of the spectrum of EDS VI; thus, the term Nevo syndrome does not refer to a distinct disorder, but is now incorporated into EDS, kyphoscoliotic form.</p>
        </sec>
        <sec id="eds6.Prevalence">
          <title>Prevalence</title>
          <p>EDS, kyphoscoliotic form is rare; the exact prevalence is unknown. A disease incidence of approximately 1:100,000 live births is a reasonable estimate.</p>
          <p>Prevalence does not vary by race or ethnicity, although many of the reported and unreported cases originated in Turkey, the Middle East, and Greece [<xref ref-type="bibr" rid="eds6.REF.giunta.2005a.158">Giunta et al 2005a</xref>, <xref ref-type="bibr" rid="eds6.REF.giunta.2005b.269">Giunta et al 2005b</xref>].</p>
          <p>Carrier frequency is estimated to be 1:150.</p>
        </sec>
      </sec>
      <sec id="eds6.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>It has been reported that <italic toggle="yes">PLOD1</italic> may be a susceptibility gene for reduced bone mineral density (BMD) [<xref ref-type="bibr" rid="eds6.REF.tasker.2006.1078">Tasker et al 2006</xref>, <xref ref-type="bibr" rid="eds6.REF.yamada.2007.791">Yamada et al 2007</xref>]. The 319G&#x0003e;A polymorphism coding for p.Ala99Thr [<xref ref-type="bibr" rid="eds6.REF.yeowell.2000.212">Yeowell &#x00026; Walker 2000</xref>] (numbering based on GenBank accession number <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=187279">M98252.1</ext-link>) has been linked to reduced BMD and an increase in the ratio of Dpyr/Pyr cross-links in urine.</p>
      </sec>
      <sec id="eds6.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Ehlers-Danlos syndrome (EDS), kyphoscoliotic form has some overlapping clinical features with other forms of EDS, particularly <related-object link-type="booklink" source-id="gene" document-id="eds" document-type="chapter">EDS, classic type</related-object> and <related-object link-type="booklink" source-id="gene" document-id="eds4" document-type="chapter">EDS, vascular type</related-object>. Abnormal wound healing and joint laxity are present in many EDS types. Although all types of EDS involve a relatively high risk for scoliosis compared to the general population, scoliosis in EDS, kyphoscoliotic form is usually more severe and of earlier onset than that seen in other EDS types. The diagnosis of EDS, kyphoscoliotic form can be confirmed by biochemical analysis of urinary Dpyr/Pyr cross-links, molecular genetic testing of <italic toggle="yes">PLOD1</italic>, or lysyl hydroxylase enzyme activity assay.</p>
        <p>Several rare conditions (designated here as EDS VIB, EDS VIC, and EDS VID) with overlapping features of EDS, kyphoscoliotic type but with normal lysyl hydroxylase enzyme activity include: </p>
        <list list-type="bullet">
          <list-item>
            <p>EDS VIB, caused by an autosomal recessive deficiency of dermatan-4-sulfotransferase 1 (D4ST-1). EDS VIB is characterized by additional clinical findings including adducted thumbs and feet [<xref ref-type="bibr" rid="eds6.REF.malfait.2010.1233">Malfait et al 2010</xref>]. </p>
          </list-item>
          <list-item>
            <p>EDS VIC, or EDS-spondylocheirodysplasia (SCD) form, caused by autosomal recessive mutations in the zinc transporter gene, <italic toggle="yes">SLC39A13</italic>. EDS VIC is characterized by additional clinical findings such as signs of skeletal dysplasia (<italic toggle="yes">spondylo</italic>) with moderate short stature and characteristic features of the hands (thenar atrophy) (<italic toggle="yes">cheiro</italic>); the urinary excretion of pyridinolines is changed to a Dpyr/Pyr ratio of approximately 1.0, falling between the ratio in controls and in EDS VIA [<xref ref-type="bibr" rid="eds6.REF.giunta.2008.1290">Giunta et al 2008</xref>].</p>
          </list-item>
          <list-item>
            <p>EDS VID, or <italic toggle="yes">FKBP14</italic>-related EDS, caused by autosomal recessive mutations in <italic toggle="yes">FKBP14</italic>, the gene which encodes the collagen-specific chaperone FKBP14. EDS VID is characterized by additional clinical findings including myopathy and neurosensorial hearing loss [<xref ref-type="bibr" rid="eds6.REF.baumann.2012.201">Baumann et al 2012</xref>]. </p>
          </list-item>
        </list>
        <p>Most congenital myopathies present with poor muscle tone and increased range of motion of small and large joints. Joint laxity can be difficult to distinguish from muscular hypotonia, particularly in infants and children. In EDS, kyphoscoliotic form, in which both hypotonia and joint laxity are present, the increased range of motion is often striking. Velvety skin texture may help distinguish EDS, kyphoscoliotic form from congenital myopathies, such as <related-object link-type="booklink" source-id="gene" document-id="mtm" document-type="chapter">X-linked myotubular myopathy</related-object>. Unlike <related-object link-type="booklink" source-id="gene" document-id="sma" document-type="chapter">spinal muscular atrophy</related-object>, EDS, kyphoscoliotic form is characterized by normal deep tendon reflexes.</p>
        <p>Many syndromic and metabolic disorders include early-onset hypotonia. In these disorders, however, the other manifestations of EDS, kyphoscoliotic form are generally absent, and additional features are usually present.</p>
        <p>Although brittle cornea syndrome (BCS) (characterized by corneal rupture following minor trauma) is characterized by skin hyperelasticity and joint hypermobility, biochemical analysis reveals normal ratios of urinary pyridinolines and lysyl hydroxylase enzyme activity [<xref ref-type="bibr" rid="eds6.REF.alhussain.2004.28">Al-Hussain et al 2004</xref>].</p>
      </sec>
      <sec id="eds6.Management">
        <title>Management</title>
        <sec id="eds6.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with Ehlers-Danlos syndrome (EDS), kyphoscoliotic form, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Musculoskeletal</bold>
</p>
              <list list-type="bullet">
                <list-item>
                  <p>Evaluation for kyphoscoliosis. Photographic and radiologic documentation of the spine is recommended in view of the progressive kyphoscoliosis. </p>
                </list-item>
                <list-item>
                  <p>Physical therapy evaluation to develop a plan for ongoing therapy to strengthen large muscle groups and prevent recurrent shoulder dislocation </p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Cardiovascular.</bold> Measurement of aortic root size and assessment of heart valves by echocardiogram at the time of diagnosis or by age five years </p>
            </list-item>
            <list-item>
              <p><bold>Ophthalmologic.</bold> Formal ophthalmologic evaluation at diagnosis for myopia, astigmatism, and potential for retinal detachment </p>
            </list-item>
            <list-item>
              <p>Medical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="eds6.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Musculoskeletal</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>Referral to an orthopedic surgeon for management of kyphoscoliosis is appropriate. </p>
            </list-item>
            <list-item>
              <p>Orthopedic surgery is not contraindicated in individuals with EDS, kyphoscoliotic form and can be performed as necessary.</p>
            </list-item>
            <list-item>
              <p> Bracing may be required to support unstable joints.</p>
            </list-item>
            <list-item>
              <p>Physical therapy is recommended for older children, adolescents, and adults to strengthen large muscle groups, particularly at the shoulder girdle, and to prevent recurrent shoulder dislocation. Swimming is recommended. </p>
            </list-item>
            <list-item>
              <p>Due to skin fragility, protective pads over knees, shins, and elbows may be helpful in preventing lacerations, particularly in children. The use of helmets in active sports is always advised.</p>
            </list-item>
          </list>
          <p><bold>Cardiovascular</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>Vigilant observation and control of blood pressure can reduce the risk of arterial rupture. </p>
            </list-item>
            <list-item>
              <p>Vascular surgery is fraught with danger. Although virtually no surgical literature exists on EDS, kyphoscoliotic form, the review by <xref ref-type="bibr" rid="eds6.REF.freeman.1996.869">Freeman et al [1996]</xref> on surgical complications of EDS, vascular type is relevant. </p>
            </list-item>
            <list-item>
              <p>Individuals with aortic dilation may require treatment with beta blockers to prevent further expansion. </p>
            </list-item>
          </list>
          <p><bold>Ophthalmologic</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>Myopia and/or astigmatism may be corrected by glasses or contact lenses. </p>
            </list-item>
            <list-item>
              <p>Laser treatment of the retina is indicated in case of imminent detachment. </p>
            </list-item>
          </list>
        </sec>
        <sec id="eds6.Prevention_of_Secondary_Complicatio">
          <title>Prevention of Secondary Complications</title>
          <p>Individuals with mitral valve prolapse should follow standard American Heart Association guidelines for antimicrobial prophylaxis.</p>
        </sec>
        <sec id="eds6.Surveillance">
          <title>Surveillance</title>
          <p>The following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Routine ophthalmologic examination for management of myopia and early detection of glaucoma or retinal detachment </p>
            </list-item>
            <list-item>
              <p>Routine examination for inguinal hernia and surgical referral as necessary </p>
            </list-item>
            <list-item>
              <p>Vigilant observation of blood pressure </p>
            </list-item>
            <list-item>
              <p>Regular follow up by an orthopedic surgeon for management of kyphoscoliosis </p>
            </list-item>
            <list-item>
              <p>Echocardiogram at five-year intervals, even if the initial echocardiogram is normal </p>
            </list-item>
          </list>
          <p>Females should be made aware of complications associated with pregnancy (see <xref ref-type="sec" rid="eds6.Pregnancy_Management">Pregnancy Management</xref>).</p>
        </sec>
        <sec id="eds6.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>In children with significant joint hyperextensibility, sports which impact the joints such as gymnastics or long-distance running should be avoided.</p>
        </sec>
        <sec id="eds6.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="eds6.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="eds6.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Affected pregnant women may be at increased risk for spontaneous abortions, premature rupture of membranes, and rupture of arteries [<xref ref-type="bibr" rid="eds6.REF.esaka.2009.515">Esaka et al 2009</xref>]. Two affected women had a total of seven pregnancies resulting in three miscarriages and four healthy children, three of whom were born vaginally at term and one of whom was born at 24 weeks; there were no maternal complications [Steinmann, unpublished]. Delivery should be performed in a medical center. </p>
        </sec>
        <sec id="eds6.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
        <sec id="eds6.Other">
          <title>Other</title>
          <p>Ascorbate therapy has been suggested as a treatment, but its effectiveness has not been biochemically proven. </p>
        </sec>
      </sec>
      <sec id="eds6.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="eds6.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Ehlers-Danlos syndrome (EDS), kyphoscoliotic form is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="eds6.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p><bold>Parents of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes and therefore carry a single copy of a disease-causing mutation in <italic toggle="yes">PLOD1</italic>. </p>
            </list-item>
            <list-item>
              <p>Heterozygotes are asymptomatic. </p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband.</bold> At conception, each sib of a proband with EDS, kyphoscoliotic form has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. </p>
          <p><bold>Offspring of a proband.</bold> The offspring of an affected individual are obligate heterozygotes. </p>
          <p><bold>Other family members.</bold> Each sib of an obligate heterozygote is at a 50% risk of being a heterozygote. </p>
        </sec>
        <sec id="eds6.Carrier_Detection">
          <title>Carrier Detection</title>
          <p><bold>Biochemical genetic testing.</bold> Although carriers do tend to have slightly elevated urinary Dpyr/Pyr ratios [<xref ref-type="bibr" rid="eds6.REF.kraenzlin.2008.1546">Kraenzlin et al 2008</xref>], carrier status cannot be reliably ascertained by biochemical testing or by enzyme assay.</p>
          <p><bold>Molecular genetic testing.</bold> Carrier testing for at-risk family members is possible once the disease-causing mutations have been identified in the family. </p>
        </sec>
        <sec id="eds6.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy. </p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers. </p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals. </p>
        </sec>
        <sec id="eds6.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p><bold>Molecular genetic testing.</bold> Prenatal diagnosis for pregnancies at increased risk is possible by analysis of DNA extracted from fetal cells obtained by amniocentesis usually performed at approximately 15 to 18 weeks' gestation or chorionic villus sampling (CVS) at approximately ten to 12 weeks' gestation. Both disease-causing alleles must be identified before prenatal testing can be performed [<xref ref-type="bibr" rid="eds6.REF.yeowell.1999.57">Yeowell &#x00026; Walker 1999</xref>, <xref ref-type="bibr" rid="eds6.REF.yeowell.2000.90">Yeowell et al 2000</xref>]. </p>
          <p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the disease-causing mutations have been identified.</p>
        </sec>
      </sec>
      <sec id="eds6.Resources">
        <title>Resources</title>
      </sec>
      <sec id="eds6.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">PLOD1</italic> is approximately 40 kb and consists of 19 exons with an unusually large first intron of 12.5 kb. The introns are of high homology, generating many potential recombination sites within the gene. Five polymorphic markers have been identified in <italic toggle="yes">PLOD1</italic>. These are located at nucleotides 318C&#x0003e;T, 319G&#x0003e;A, 382G&#x0003e;T, 1230C&#x0003e;T, and 1656A&#x0003e;C in the coding region and, in the noncoding region, at 2349G&#x0003e;A (numbering based on GenBank accession number <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/M98252.1">M98252.1</ext-link>). For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="eds6" object-id="eds6.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants.</bold> More than 20 different mutations in <italic toggle="yes">PLOD1</italic> have been associated with EDS, kyphoscoliotic form [<xref ref-type="bibr" rid="eds6.REF.yeowell.2000.212">Yeowell &#x00026; Walker 2000</xref>, <xref ref-type="bibr" rid="eds6.REF.giunta.2005b.269">Giunta et al 2005b</xref>, <xref ref-type="bibr" rid="eds6.REF.walker.2005.914">Walker et al 2005</xref>]. These pathogenic variants are located throughout the gene.</p>
        <list list-type="bullet">
          <list-item>
            <p>The most common pathogenic variant, an 8.9-kb duplication of seven exons (exons 10 to 16), is caused by a homologous recombination event between identical 44-bp Alu sequences in introns 9 and 16 [<xref ref-type="bibr" rid="eds6.REF.pousi.1994.899">Pousi et al 1994</xref>]. The allele frequency of the duplication is 18.3% in probands with EDS, kyphoscoliotic form from 53 families [<xref ref-type="bibr" rid="eds6.REF.yeowell.2005.353">Yeowell et al 2005</xref>]. Intragenic deletions are also reported (see <xref ref-type="table" rid="eds6.T.summary_of_molecular_genetic_test">Table 1</xref>).</p>
          </list-item>
          <list-item>
            <p>The second most common mutation in <italic toggle="yes">PLOD1</italic> occurs in exon 14 and results in chain termination at codon 511 for tyrosine (p.Tyr511Ter). The allele frequency of this mutation in probands with EDS, kyphoscoliotic form is 10%. </p>
          </list-item>
        </list>
        <p>The two mutations have been linked by haplotype analysis to a common ancestral gene [<xref ref-type="bibr" rid="eds6.REF.yeowell.2000.212">Yeowell &#x00026; Walker 2000</xref>].</p>
        <table-wrap id="eds6.T.plod1_pathogenic_variants_discuss" position="anchor" orientation="portrait">
          <label>Table 2.</label>
          <caption>
            <p><italic toggle="yes">PLOD1</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table>
            <tbody>
              <tr>
                <th id="hd_b_eds6.T.plod1_pathogenic_variants_discuss_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_b_eds6.T.plod1_pathogenic_variants_discuss_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                <th id="hd_b_eds6.T.plod1_pathogenic_variants_discuss_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
              <tr>
                <td headers="hd_b_eds6.T.plod1_pathogenic_variants_discuss_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.1533C&#x0003e;G</td>
                <td headers="hd_b_eds6.T.plod1_pathogenic_variants_discuss_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Tyr511Ter</td>
                <td headers="hd_b_eds6.T.plod1_pathogenic_variants_discuss_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000302.3">NM_000302.3</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000293.2">NP_000293.2</ext-link>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="eds6.TF.2">
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants. </p>
            </fn>
            <fn id="eds6.TF.2.1">
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The cDNA for <italic toggle="yes">PLOD1</italic> codes for a polypeptide of 727 amino acids, including a signal peptide of 18 residues. Lysyl hydroxylase 1 exists as a dimer of identical subunits of molecular weight approximately 80-85 kd, depending on the state of glycosylation. The enzyme requires Fe<sup>2+</sup>, &#x003b1;-ketoglutarate, O<sub>2</sub>, and ascorbate as cofactors. The C-terminal region is well conserved across species and is thought to contain the active site of the enzyme [<xref ref-type="bibr" rid="eds6.REF.yeowell.2002.1">Yeowell 2002</xref>]. </p>
        <p><bold>Abnormal gene product.</bold> Western blot analysis using polyclonal antibody to recombinant LH1 showed (in contrast to EDS VIB) decreased levels of LH1 in two individuals with EDS, kyphoscoliotic form [<xref ref-type="bibr" rid="eds6.REF.walker.2004.155">Walker et al 2004</xref>]. </p>
      </sec>
      <sec id="eds6.References">
        <title>References</title>
        <sec id="eds6.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="eds6.Literature_Cited.reflist0">
            <ref id="eds6.REF.alhussain.2004.28">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Al-Hussain</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeisberger</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huber</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giunta</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Brittle cornea syndrome and its delineation from the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VI): report on 23 patients and review of the literature.</article-title>
                <source>Am J Med Genet A</source>
                <year>2004</year>
                <volume>124A</volume>
                <fpage>28</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">14679583</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.baumann.2012.201">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baumann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giunta</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krabichler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>R&#x000fc;schendorf</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zoppi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colombi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bittner</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quijano-Roy</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cirak</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schreiber</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zou</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carlier</surname>
                    <given-names>RY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amberger</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deutschmann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straub</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rohrbach</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rost&#x000e1;sy</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karall</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000f6;nnemann</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zschocke</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fauth</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in FKBP14 cause a variant of Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy and hearing loss.</article-title>
                <source>Am J Hum Genet</source>
                <year>2012</year>
                <volume>90</volume>
                <fpage>201</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">22265013</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.beighton.1998.31">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beighton</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Paepe</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsipouras</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wenstrup</surname>
                    <given-names>RJ</given-names>
                  </name>
                </person-group>
                <article-title>Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK).</article-title>
                <source>Am J Med Genet</source>
                <year>1998</year>
                <volume>77</volume>
                <fpage>31</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9557891</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.esaka.2009.515">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Esaka</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Golde</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stever</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>RL</given-names>
                  </name>
                </person-group>
                <article-title>A maternal and perinatal mortality in pregnancy complicated by the kyphoscoliotic form of Ehlers-Danlos syndrome.</article-title>
                <source>Obstet Gynecol</source>
                <year>2009</year>
                <volume>113</volume>
                <fpage>515</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19155940</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.freeman.1996.869">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swegle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sise</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>The surgical complications of Ehlers-Danlos syndrome.</article-title>
                <source>Am Surg</source>
                <year>1996</year>
                <volume>62</volume>
                <fpage>869</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">8813174</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.giunta.2009.346">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Giunta</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000fc;rer-Chambaz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B.</given-names>
                  </name>
                </person-group>
                <article-title>Novel human pathological mutations. Gene symbol: PLOD1. Disease: Ehlers-Danlos syndrome type VIA, kyphoscoliotic type.</article-title>
                <source>Hum Genet</source>
                <year>2009</year>
                <volume>125</volume>
                <fpage>346</fpage>
                <pub-id pub-id-type="pmid">19320026</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.giunta.2008.1290">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Giunta</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El&#x000e7;ioglu</surname>
                    <given-names>NH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albrecht</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eich</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chambaz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janecke</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yeowell</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weis</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eyre</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraenzlin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Spondylocheiro dysplastic form of the Ehlers-Danlos syndrome &#x02013; an autosomal-recessive entity caused by mutations in the zinc transporter gene SLC39A13.</article-title>
                <source>Am J Hum Genet</source>
                <year>2008</year>
                <volume>82</volume>
                <fpage>1290</fpage>
                <lpage>305</lpage>
                <pub-id pub-id-type="pmid">18513683</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.giunta.2005a.158">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Giunta</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Randolph</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Gazali</surname>
                    <given-names>LI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraenzlin</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Nevo syndrome is allelic to the kyphoscoliotic type of the Ehlers-Danlos syndrome (EDS VIA).</article-title>
                <source>Am J Med Genet A</source>
                <year>2005a</year>
                <volume>133A</volume>
                <fpage>158</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">15666309</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.giunta.2005b.269">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Giunta</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Randolph</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Mutation analysis of the PLOD1 gene: an efficient multistep approach to the molecular diagnosis of the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA).</article-title>
                <source>Mol Genet Metab</source>
                <year>2005b</year>
                <volume>86</volume>
                <fpage>269</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">15979919</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.heim.1998.708">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Heim</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raghunath</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meiss</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heise</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myllyla</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlschutter</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Ehlers-Danlos syndrome type VI (EDS VI): problems of diagnosis and management.</article-title>
                <source>Acta Paediatr</source>
                <year>1998</year>
                <volume>87</volume>
                <fpage>708</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">9686670</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.kraenzlin.2008.1546">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kraenzlin</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraenzlin</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giunta</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Automated HPLC assay for urinary collagen cross-links: effect of age, menopause, and metabolic bone diseases.</article-title>
                <source>Clin Chem</source>
                <year>2008</year>
                <volume>54</volume>
                <fpage>1546</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">18653826</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.malfait.2010.1233">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Malfait</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syx</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vlummens</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Symoens</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nampoothiri</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hermanns-L&#x000ea;</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Laer</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Paepe</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Musculocontractural Ehlers-Danlos syndrome (former EDS type VIB) and adducted thumb clubfoot syndrome (ATCS) represent a single clinical entity caused by mutations in the dermatan-4-sulfotransferase 1 encoding CHST14 gene.</article-title>
                <source>Hum Mutat.</source>
                <year>2010</year>
                <volume>31</volume>
                <fpage>1233</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20842734</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.mayer.2013.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mayer</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennerknecht</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Clinical utility gene card for: Ehlers-Danlos syndrome types I&#x02013;VII and variants - update 2012.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2013</year>
              </element-citation>
            </ref>
            <ref id="eds6.REF.pinnell.1972.1013">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pinnell</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krane</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kenzora</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glimcher</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>A heritable disorder of connective tissue. Hydroxylysine-deficient collagen disease.</article-title>
                <source>N Engl J Med</source>
                <year>1972</year>
                <volume>286</volume>
                <fpage>1013</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">5016372</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.pousi.1994.899">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pousi</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hautala</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heikkinen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pajunen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kivirikko</surname>
                    <given-names>KI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myllyla</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Alu-Alu recombination results in a duplication of seven exons in the lysyl hydroxylase gene in a patient with the type VI variant of Ehlers-Danlos syndrome.</article-title>
                <source>Am J Hum Genet</source>
                <year>1994</year>
                <volume>55</volume>
                <fpage>899</fpage>
                <lpage>906</lpage>
                <pub-id pub-id-type="pmid">7977351</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.pousi.1998.55">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pousi</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hautala</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hyland</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schr&#x000f6;ter</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eckes</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kivirikko</surname>
                    <given-names>KI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myllyl&#x000e4;</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>A compound heterozygote patient with Ehlers-Danlos syndrome type VI has a deletion in one allele and a splicing defect in the other allele of the lysyl hydroxylase gene.</article-title>
                <source>Hum Mutat.</source>
                <year>1998</year>
                <volume>11</volume>
                <fpage>55</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">9450904</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.rohrbach.2011.46">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rohrbach</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vandersteen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yi&#x0015f;</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serdaroglu</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ataman</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chopra</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kariminejad</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraenzlin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marcelis</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giunta</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Phenotypic variability of the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA): clinical, molecular and biochemical delineation.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <year>2011</year>
                <volume>6</volume>
                <fpage>46</fpage>
                <pub-id pub-id-type="pmid">21699693</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.steinmann.1995.1505">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eyre</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shao</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Urinary pyridinoline cross-links in Ehlers-Danlos syndrome type VI</article-title>
                <source>Am J Hum Genet</source>
                <year>1995</year>
                <volume>57</volume>
                <fpage>1505</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8533783</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.steinmann.2002.1">
              <mixed-citation publication-type="book">Steinmann B, Royce PM, Superti-Furga A. The Ehlers-Danlos syndrome. In: Royce PM, Steinmann B, eds. <italic toggle="yes">Connective Tissue and its Heritable Disorders: Molecular, Genetic and Medical Aspects.</italic> New York, NY: Wiley-Liss; 2002:431-523.</mixed-citation>
            </ref>
            <ref id="eds6.REF.tasker.2006.1078">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tasker</surname>
                    <given-names>PN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macdonald</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fraser</surname>
                    <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reid</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ralston</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albagha</surname>
                    <given-names>OM</given-names>
                  </name>
                </person-group>
                <article-title>Association of PLOD1 polymorphisms with bone mineral density in a population-based study of women from the UK.</article-title>
                <source>Osteoporos Int</source>
                <year>2006</year>
                <volume>17</volume>
                <fpage>1078</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">16758144</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.walker.2005.914">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Overstreet</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siddiqui</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Paepe</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ceylaner</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malfait</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Symoens</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atsawasuwan</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamauchi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ceylaner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bank</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yeowell</surname>
                    <given-names>HN</given-names>
                  </name>
                </person-group>
                <article-title>A novel mutation in the lysyl hydroxylase 1 gene causes decreased lysyl hydroxylase activity in an Ehlers-Danlos VIA patient.</article-title>
                <source>J Invest Dermatol</source>
                <year>2005</year>
                <volume>124</volume>
                <fpage>914</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15854030</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.walker.2004.155">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Overstreet</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willing</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marini</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cabral</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pals</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bristow</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atsawasuwan</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamauchi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yeowell</surname>
                    <given-names>HN</given-names>
                  </name>
                </person-group>
                <article-title>Heterogeneous basis of the type VIB form of Ehlers-Danlos syndrome (EDS VIB) that is unrelated to decreased collagen lysyl hydroxylation.</article-title>
                <source>Am J Med Genet A</source>
                <year>2004</year>
                <volume>131</volume>
                <fpage>155</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">15523625</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.yamada.2007.791">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ando</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimokata</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Association of candidate gene polymorphisms with bone mineral density in community-dwelling Japanese women and men.</article-title>
                <source>Int J Mol Med</source>
                <year>2007</year>
                <volume>19</volume>
                <fpage>791</fpage>
                <lpage>801</lpage>
                <pub-id pub-id-type="pmid">17390085</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.yeowell.2002.1">
              <mixed-citation publication-type="book">Yeowell HN. Isoforms of lysyl hydroxylase. In: Creighton T, ed. <italic toggle="yes">Wiley Encyclopedia of Molecular Medicine</italic>. New York, NY: JW Wiley; 2002:1980-4.</mixed-citation>
            </ref>
            <ref id="eds6.REF.yeowell.1999.57">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yeowell</surname>
                    <given-names>HN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>LC</given-names>
                  </name>
                </person-group>
                <article-title>Prenatal exclusion of Ehlers-Danlos syndrome type VI by mutational analysis.</article-title>
                <source>Proc Assoc Am Physicians</source>
                <year>1999</year>
                <volume>111</volume>
                <fpage>57</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">9893157</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.yeowell.2000.212">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yeowell</surname>
                    <given-names>HN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>LC</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI.</article-title>
                <source>Mol Genet Metab</source>
                <year>2000</year>
                <volume>71</volume>
                <fpage>212</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">11001813</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.yeowell.2000.90">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yeowell</surname>
                    <given-names>HN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farmer</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heikinnen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myllyla</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Mutational analysis of the lysyl hydroxylase 1 gene in six unrelated patients affected by Ehlers-Danlos syndrome type VI; prenatal exclusion of this disorder in one family.</article-title>
                <source>Hum Mutat</source>
                <year>2000</year>
                <volume>16</volume>
                <fpage>90</fpage>
                <pub-id pub-id-type="pmid">10874315</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.yeowell.2005.353">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yeowell</surname>
                    <given-names>HN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>LM</given-names>
                  </name>
                </person-group>
                <article-title>An Ehlers-Danlos syndrome type VIA patient with cystic malformations of the meninges.</article-title>
                <source>Eur J Dermatol</source>
                <year>2005</year>
                <volume>15</volume>
                <fpage>353</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16172044</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="eds6.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="eds6.Suggested_Reading.reflist0">
            <ref id="eds6.REF.abel.2006.582">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Abel</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrasco</surname>
                    <given-names>LR</given-names>
                  </name>
                </person-group>
                <article-title>Ehlers-Danlos syndrome: classifications, oral manifestations, and dental considerations.</article-title>
                <source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source>
                <year>2006</year>
                <volume>102</volume>
                <fpage>582</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">17052632</pub-id>
              </element-citation>
            </ref>
            <ref id="eds6.REF.byers.2014.1">
              <mixed-citation publication-type="book">Byers PH. Disorders of collagen biosynthesis and structure. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID).</italic> 2015. New York, NY: McGraw-Hill. Chap 205.</mixed-citation>
            </ref>
            <ref id="eds6.REF.burrows.2011.1">
              <mixed-citation publication-type="book">Burrows NP, Sidhu-Malik N, Yeowell H. Ehlers-Danlos syndromes. In: Irvine A, Hoeger P, Yan A, eds. <italic toggle="yes">Harper&#x02019;s Textbook of Pediatric Dermatology.</italic> Chap 142. 3 ed. Hoboken, NJ: Wiley-Blackwell; 2011.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="eds6.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="eds6.Author_History">
          <title>Author History</title>
          <p>Beat Steinmann, MD (2008-present) Richard Wenstrup, MD; Cincinnati Children's Hospital Medical Center (1999-2008) Heather N Yeowell, PhD (2005-present) </p>
        </sec>
        <sec id="eds6.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>24 January 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>19 February 2008 (me) Comprehensive update posted to live Web site </p>
            </list-item>
            <list-item>
              <p>12 July 2005 (me) Comprehensive update posted to live Web site </p>
            </list-item>
            <list-item>
              <p>12 March 2003 (me) Comprehensive update posted to live Web site </p>
            </list-item>
            <list-item>
              <p>2 February 2000 (me) Review posted to live Web site </p>
            </list-item>
            <list-item>
              <p>7 April 1999 (rw) Original submission </p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
